Amarin Corp Plc (AMRN)

[sts66]

Amarin has multiple next generation Vascepa-Plus in the works

Since when? They've only talked about a V + statin combo drug in the past - I haven't seen this new patent yet, but it could be just a way to prevent generics from making a different combo drug - not that AMRN has any intention of spending the money needed to actually run a trial and try to get it FDA approved. Hell, they've had the statin combo patent for many years and haven't done a damn thing with it, beyond maybe some pre-clinical petri dish studies.